“…Using BPL reconstruction in clinical studies enables improved lesion detection, and this has been shown in a wide variety of studies, for example, for 18 F-FDG in lung nodules [17,19], mediastinal nodes [20] and liver metastases [21]. PET imaging with other tracers also benefits from BPL reconstruction [17], for example, 68 Ga-PSMA [22,23], 68 Ga-DOTATOC [24], 68 Ga-RM2 [25], 90 Y-SIRT [26,27], 18 F-PSMA [28], 18 F-NaF [29], 68 Ga-citrate [30], 18 F-FACBC [31], 13 N-NH3 [32], 11 C-acetate [24] and 89 Zr-immuno-PET [33]. In addition, and perhaps most importantly, BPL is particularly advantageous in patients with high BMI [34,35], because they usually have the greatest background image noise where both the detection and quantification of small abnormalities are most problematic.…”